PT - JOURNAL ARTICLE AU - Sofia Sirvent AU - Andres Vallejo AU - Emma Corden AU - Ying Teo AU - James Davies AU - Kalum Clayton AU - Eleanor Seaby AU - Chester Lai AU - Sarah Ennis AU - Rfeef Alyami AU - Lareb Dean AU - Matthew Loxham AU - Sarah Horswill AU - Eugene Healy AU - Graham Roberts AU - Nigel J. Hall AU - Clare L. Bennett AU - Peter Friedmann AU - Harinder Singh AU - Michael Ardern-Jones AU - Marta E Polak TI - TNFα SIGNALLING IN THE CUTANEOUS IMMUNE NETWORK INSTRUCTS LOCAL Th17 ALLERGEN-SPECIFIC INFLAMMATORY RESPONSES IN ATOPIC DERMATITIS AID - 10.1101/2021.10.07.21264714 DP - 2021 Jan 01 TA - medRxiv PG - 2021.10.07.21264714 4099 - http://medrxiv.org/content/early/2021/10/11/2021.10.07.21264714.short 4100 - http://medrxiv.org/content/early/2021/10/11/2021.10.07.21264714.full AB - Accurate regulation of cutaneous immunity is fundamental for human health and quality of life but is severely compromised in inflammatory skin disease. To investigate the molecular crosstalk underpinning tolerance vs inflammation in human skin, we set up a human in vivo allergen challenge study, exposing patients with atopic dermatitis (AD) to house dust mite (HDM). Analyses of transcriptional programmes at the population and single cell levels in parallel with immunophenotyping of resident and infiltrating immune cells indicated that inflammatory responses to HDM were associated with immune activation in Langerhans cells (LCs) and cutaneous T cells. High basal level of TNFα production by cutaneous Th17 T cells predisposed to an inflammatory reaction and resulted in formation of hub structures where LCs and T cells interacted, leading to loss of functional programming in LCs. Additionally, single nucleotide polymorphisms in MT1X gene associated with enhanced expression of metallothioneins and transcriptional programmes encoding antioxidant defences across skin cell types in non-reactive patients, were protective against T cell mediated inflammation. Our results provide a unique insight into the dynamics of immune regulation in the human skin and define regulatory circuits that can be harnessed to improve skin health and treat disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded in whole by the Wellcome Trust [Sir Henry Dale Fellowship 109377/Z/15/Z].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:South East Coast - Brighton & Sussex Research Ethics Committee in adherence to Helsinki Guidelines gave ethical approval for this work (approval: 16/LO/0999)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study will be available upon reasonable request to the authors following acceptance for publication by peer review.